Odyssey Therapeutics has become the latest biotech to voyage to the public markets via an upsized $304 million IPO this morning.
Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula
Odyssey Therapeutics has become the latest biotech to voyage to the public markets via an upsized $304 million IPO this morning.